COSMOS Pharmaceutical Future Growth
Future criteria checks 2/6
COSMOS Pharmaceutical is forecast to grow earnings and revenue by 6.7% and 7% per annum respectively. EPS is expected to grow by 6.6% per annum. Return on equity is forecast to be 10.7% in 3 years.
Key information
6.7%
Earnings growth rate
6.6%
EPS growth rate
Consumer Retailing earnings growth | 12.2% |
Revenue growth rate | 7.0% |
Future return on equity | 10.7% |
Analyst coverage | Good |
Last updated | 15 Aug 2024 |
Recent future growth updates
Recent updates
An Intrinsic Calculation For COSMOS Pharmaceutical Corporation (TSE:3349) Suggests It's 41% Undervalued
Aug 17COSMOS Pharmaceutical (TSE:3349) Will Want To Turn Around Its Return Trends
Aug 01Subdued Growth No Barrier To COSMOS Pharmaceutical Corporation's (TSE:3349) Price
Jun 28We Think COSMOS Pharmaceutical (TSE:3349) Can Stay On Top Of Its Debt
Jun 10COSMOS Pharmaceutical Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 17Some Shareholders Feeling Restless Over COSMOS Pharmaceutical Corporation's (TSE:3349) P/E Ratio
Mar 16Returns On Capital At COSMOS Pharmaceutical (TSE:3349) Paint A Concerning Picture
Feb 28Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
5/31/2027 | 1,205,808 | 30,167 | 10,833 | 60,345 | 10 |
5/31/2026 | 1,128,322 | 27,718 | 5,671 | 56,794 | 13 |
5/31/2025 | 1,043,560 | 25,945 | 3,929 | 48,863 | 12 |
5/31/2024 | 964,989 | 24,454 | -635 | 55,175 | N/A |
2/29/2024 | 936,706 | 24,871 | N/A | N/A | N/A |
11/30/2023 | 900,111 | 24,085 | 681 | 54,534 | N/A |
8/31/2023 | 863,228 | 23,824 | N/A | N/A | N/A |
5/31/2023 | 827,697 | 23,797 | 7,798 | 54,434 | N/A |
2/28/2023 | 802,831 | 22,983 | N/A | N/A | N/A |
11/30/2022 | 788,292 | 23,209 | -3,655 | 41,973 | N/A |
8/31/2022 | 772,127 | 23,393 | N/A | N/A | N/A |
5/31/2022 | 755,414 | 23,155 | -11,303 | 32,194 | N/A |
2/28/2022 | 743,612 | 22,030 | N/A | N/A | N/A |
11/30/2021 | 733,387 | 25,329 | -5 | 35,596 | N/A |
8/31/2021 | 726,672 | 25,909 | N/A | N/A | N/A |
5/31/2021 | 726,424 | 27,156 | 1,811 | 27,875 | N/A |
2/28/2021 | 733,223 | 28,777 | N/A | N/A | N/A |
11/30/2020 | 723,309 | 25,736 | 28,882 | 50,935 | N/A |
8/31/2020 | 709,064 | 23,876 | N/A | N/A | N/A |
5/31/2020 | 684,403 | 21,435 | 39,513 | 65,461 | N/A |
2/29/2020 | 653,527 | 20,217 | N/A | N/A | N/A |
11/30/2019 | 638,034 | 18,951 | 10,653 | 38,209 | N/A |
8/31/2019 | 622,103 | 19,349 | N/A | N/A | N/A |
5/31/2019 | 611,137 | 19,185 | 5,339 | 34,379 | N/A |
2/28/2019 | 597,715 | 18,966 | N/A | N/A | N/A |
11/30/2018 | 585,536 | 18,857 | 1,302 | 30,947 | N/A |
8/31/2018 | 572,807 | 17,880 | N/A | N/A | N/A |
5/31/2018 | 557,999 | 17,633 | 3,135 | 32,586 | N/A |
2/28/2018 | 542,936 | 17,510 | N/A | N/A | N/A |
11/30/2017 | 526,523 | 17,313 | N/A | 35,488 | N/A |
8/31/2017 | 514,880 | 18,239 | N/A | N/A | N/A |
5/31/2017 | 502,732 | 18,215 | N/A | 36,938 | N/A |
2/28/2017 | 490,037 | 15,812 | N/A | N/A | N/A |
11/30/2016 | 477,739 | 14,981 | N/A | 34,300 | N/A |
8/31/2016 | 463,517 | 13,679 | N/A | N/A | N/A |
5/31/2016 | 447,273 | 12,435 | N/A | 30,986 | N/A |
2/29/2016 | 433,328 | 12,738 | N/A | N/A | N/A |
11/30/2015 | 423,817 | 12,474 | N/A | 22,426 | N/A |
8/31/2015 | 414,046 | 12,350 | N/A | N/A | N/A |
5/31/2015 | 408,466 | 11,694 | N/A | 19,454 | N/A |
2/28/2015 | 402,690 | 10,671 | N/A | N/A | N/A |
11/30/2014 | 392,527 | 10,286 | N/A | 26,260 | N/A |
8/31/2014 | 382,823 | 10,193 | N/A | N/A | N/A |
5/31/2014 | 371,825 | 10,600 | N/A | 25,962 | N/A |
2/28/2014 | 360,162 | 10,366 | N/A | N/A | N/A |
11/30/2013 | 349,966 | 9,975 | N/A | 17,627 | N/A |
8/31/2013 | 340,843 | 9,549 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 3349's forecast earnings growth (6.7% per year) is above the savings rate (0.3%).
Earnings vs Market: 3349's earnings (6.7% per year) are forecast to grow slower than the JP market (8.5% per year).
High Growth Earnings: 3349's earnings are forecast to grow, but not significantly.
Revenue vs Market: 3349's revenue (7% per year) is forecast to grow faster than the JP market (4.2% per year).
High Growth Revenue: 3349's revenue (7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 3349's Return on Equity is forecast to be low in 3 years time (10.7%).